We serve 2,2-Diethoxyethylamine CAS:645-36-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2,2-Diethoxyethylamine
CAS.NO:645-36-3
Molecular Formula:C6H15NO2
Molecular Weight:133.18900
Synonyms:
2,2-diethoxyethanamine
Ethanamine, 2,2-diethoxy-
Physical and Chemical Properties:
Density: 0.916 g / mL at 25 ° C (lit.)
Boiling point: 162-163 ° C (lit.)
Melting point: -78
Flash point: 114 ° F
Refractive index: n20 / D 1.417 (lit.)
Specification:
Appearance:Clear colorless to light yellow liquid
Purity:≥98.0%
Moisture Content: 0.25%
Impurity: 0.3%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:Aminoacetaldehyde Diethyl Acetal is a useful synthetic intermediate. It can be used as a building block for imidazole containing compounds such as 5-bromo-2-(1H-imidazol-2-yl)pyridine and heteroaryl-2-imidazoles.
Contact us for information like 2,2-Diethoxyethylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethanamine, 2,2-diethoxy- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2-Diethoxyethylamine Use and application,Ethanamine, 2,2-diethoxy- technical grade,usp/ep/jp grade.
Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.O-Desmorpholinopropyl Gefitinib manufacturer The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.2,5-Dichloro-4-aminophenol supplier The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.N-(hydroxymethyl)phthalimide vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.
